- Home
- PRVA
as 08-28-2025 3:34pm EST
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | ARLINGTON |
| Market Cap: | 2.6B | IPO Year: | 2021 |
| Target Price: | $28.23 | AVG Volume (30 days): | 964.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.11 | EPS Growth: | -8.47 |
| 52 Week Low/High: | $16.47 - $26.09 | Next Earning Date: | 08-07-2025 |
| Revenue: | $1,900,071,000 | Revenue Growth: | 12.05% |
| Revenue Growth (this year): | 95.64% | Revenue Growth (next year): | 10.27% |
Latest Privia Health Group Inc. News
PRVA Breaking Stock News: Dive into PRVA Ticker-Specific Updates for Smart Investing
StockStory
2 months ago
The Top 5 Analyst Questions From Privia Health’s Q1 Earnings Call
Argus Research
2 months ago
PRVA: Lowering target price to $24.00
StockStory
2 months ago
3 Small-Cap Stocks in Hot Water
Insider Monkey
2 months ago
Privia Health Group, Inc. (PRVA) Earns Top Pick Status from TD Cowen
StockStory
2 months ago
Q1 Rundown: Omnicell (NASDAQ:OMCL) Vs Other Healthcare Technology for Providers Stocks
Argus Research
3 months ago
PRVA: What does Argus have to say about PRVA?
StockStory
3 months ago
PRVA Q1 Earnings Call: Arizona Expansion and Value-Based Care Execution
StockStory
3 months ago
1 of Wall Street’s Favorite Stock on Our Watchlist and 2 to Think Twice About
Compare PRVA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PRVA Privia Health Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.